Loading data
PMINYSE
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 4.94 m USD | 4.39 m USD | 5.04 m USD |
| Cost of revenue | 5.14 m USD | 4.5 m USD | 7.35 m USD |
| Gross profit | -204 k USD | -112 k USD | -2.31 m USD |
| Research and development expense | 3.05 m USD | 3.38 m USD | 2.21 m USD |
| Selling, general and administrative expense | 10 m USD | 10.22 m USD | 10.98 m USD |
| Operating profit | -13.26 m USD | -13.71 m USD | -15.5 m USD |
| Profit before tax | -26.97 m USD | -21.07 m USD | -15.57 m USD |
| Income tax expense | 35 k USD | -15 k USD | -2 k USD |
| Net income (reported basis) | -27 m USD | -21.06 m USD | -15.57 m USD |
| Net income attributable to common shareholders | -27 m USD | -23.74 m USD | -18 m USD |
| Basic earnings per share | -0.75 USD/share | -2.99 USD/share | -2.27 USD/share |
| Diluted earnings per share | -0.75 USD/share | -2.99 USD/share | -2.27 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.